Total Force Anthrax Vaccine Immunization Program: Controversy and Conflagration

Total Force Anthrax Vaccine Immunization Program: Controversy and Conflagration

DSpace/Manakin Repository

Total Force Anthrax Vaccine Immunization Program: Controversy and Conflagration

dc.contributor.advisor	Hutt, Peter Barton	en_US
dc.contributor.author	Corrigan, Shara L.	en_US
dc.date.accessioned	2012-07-06T22:00:41Z
dc.date.issued	2001	en_US
dc.identifier.citation	Total Force Anthrax Vaccine Immunization Program: Controversy and Conflagration (2001 Third Year Paper)	en
dc.identifier.uri	http://nrs.harvard.edu/urn-3:HUL.InstRepos:8965604
dc.description.abstract	Washington, D.C. has perceived the threat of anthrax from any of several hostile parties. The offer of protection comes in the form of the Anthrax Vaccine Immunization Program (â€&oelig;AVIPâ€). On 18 May 1998, Secretary of Defense William S. Cohen signed the Total Force Immunization Directive to provide the Anthrax Vaccine Adsorbed (â€&oelig;AVAâ€) to all active and reserve Armed Forces members over a period of seven years. The question of whether Secretary Cohen was right is one that has yet to be answered. The AVIP is a massive program to be enacted in three phases. Even prior to the programâ€™s inception, Secretary Cohen attached four conditions that had to be met before proceeding. By the middle of 1998, the Department of Defense was satisfied that all four conditions had been met and proceeded to implement AVIP. Subsequently, each of the four conditions has been challenged.Legal challenge, personal resistance, poor implementation, loss of personnel, and developing health concerns plagued the Program.	en
dc.language.iso	en_US	en
dash.license	LAA	en_US
dc.subject	Food and Drug Law	en
dc.subject	anthrax	en
dc.subject	AVIP	en
dc.subject	innoculation	en
dc.subject	vaccine	en
dc.title	Total Force Anthrax Vaccine Immunization Program: Controversy and Conflagration	en
dc.type	Paper (for course/seminar/workshop)	en_US
dc.date.available	2012-07-06T22:00:41Z